New England Capital Financial Advisors LLC Abbott Laboratories Transaction History
New England Capital Financial Advisors LLC
- $193 Billion
- Q3 2024
A detailed history of New England Capital Financial Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, New England Capital Financial Advisors LLC holds 461 shares of ABT stock, worth $54,056. This represents 0.03% of its overall portfolio holdings.
Number of Shares
461
Previous 523
11.85%
Holding current value
$54,056
Previous $54.3 Million
3.26%
% of portfolio
0.03%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding ABT
# of Institutions
3,184Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19.7 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.4 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$9 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.71 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.25 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $205B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...